APO RESEARCH · REPORT
Tumor Ablation
This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.
Product & engineering
Understand the product.
This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.
Selected research
Industry Research
Tumor Ablation Industry Research Report 2026
Market perspective
This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.
Global Tumor Ablation key players include Chongqing Haifu Medical, HealthTronics, AngioDynamics, Boston Scientific, Medtronic, etc. Global top five manufacturers hold a share about 55%.
North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent. In terms of product, Radiofrequency (RF) Ablation is the largest segment, with a share about 40%. And in terms of application, the largest application is Lung Cancer, followed by Liver Cancer, Kidney Cancer, etc.
Read the full market overview
Report Scope
This report quantifies the global Tumor Ablation market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tumor Ablation Market by Company
Angiodynamics
Medtronic
Boston Scientific
Misonix
Sonacare Medical
EDAP TMS
Chongqing Haifu Medical
HealthTronics
J &J
Tumor Ablation Segment by Type
Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Other Technologies
Tumor Ablation Segment by Application
Liver Cancer
Lung Cancer
Kidney Cancer
Others
Tumor Ablation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Ablation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Ablation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Ablation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tumor Ablation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tumor Ablation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tumor Ablation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Radiofrequency (RF) Ablation
- Microwave Ablation
- Cryoablation
- Other Technologies
Applications
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Others
Companies covered
- Angiodynamics
- Medtronic
- Boston Scientific
- Misonix
- Sonacare Medical
- EDAP TMS
- Chongqing Haifu Medical
- HealthTronics
- J &J
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tumor Ablation Market Size (2021-2032)
- 2.2.2 Global Tumor Ablation Sales (2021-2032)
- 2.2.3 Global Tumor Ablation Market Average Price (2021-2032)
- 2.3 Tumor Ablation by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Radiofrequency (RF) Ablation
- 2.3.3 Microwave Ablation
- 2.3.4 Cryoablation
- 2.3.5 Other Technologies
- 2.4 Tumor Ablation by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Liver Cancer
- 2.4.3 Lung Cancer
- 2.4.4 Kidney Cancer
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tumor Ablation Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tumor Ablation Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Tumor Ablation Revenue of Manufacturers (2021-2026)
- 3.4 Global Tumor Ablation Average Price by Manufacturers (2021-2026)
- 3.5 Global Tumor Ablation Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tumor Ablation, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tumor Ablation, Product Type & Application
- 3.8 Global Manufacturers of Tumor Ablation, Established Date
- 3.9 Global Tumor Ablation Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Angiodynamics
- 4.1.1 Angiodynamics Company Information
- 4.1.2 Angiodynamics Business Overview
- 4.1.3 Angiodynamics Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Angiodynamics Tumor Ablation Product Portfolio
- 4.1.5 Angiodynamics Recent Developments
- 4.2 Medtronic
- 4.2.1 Medtronic Company Information
- 4.2.2 Medtronic Business Overview
- 4.2.3 Medtronic Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Medtronic Tumor Ablation Product Portfolio
- 4.2.5 Medtronic Recent Developments
- 4.3 Boston Scientific
- 4.3.1 Boston Scientific Company Information
- 4.3.2 Boston Scientific Business Overview
- 4.3.3 Boston Scientific Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Boston Scientific Tumor Ablation Product Portfolio
- 4.3.5 Boston Scientific Recent Developments
- 4.4 Misonix
- 4.4.1 Misonix Company Information
- 4.4.2 Misonix Business Overview
- 4.4.3 Misonix Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Misonix Tumor Ablation Product Portfolio
- 4.4.5 Misonix Recent Developments
- 4.5 Sonacare Medical
- 4.5.1 Sonacare Medical Company Information
- 4.5.2 Sonacare Medical Business Overview
- 4.5.3 Sonacare Medical Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sonacare Medical Tumor Ablation Product Portfolio
- 4.5.5 Sonacare Medical Recent Developments
- 4.6 EDAP TMS
- 4.6.1 EDAP TMS Company Information
- 4.6.2 EDAP TMS Business Overview
- 4.6.3 EDAP TMS Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 EDAP TMS Tumor Ablation Product Portfolio
- 4.6.5 EDAP TMS Recent Developments
- 4.7 Chongqing Haifu Medical
- 4.7.1 Chongqing Haifu Medical Company Information
- 4.7.2 Chongqing Haifu Medical Business Overview
- 4.7.3 Chongqing Haifu Medical Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Chongqing Haifu Medical Tumor Ablation Product Portfolio
- 4.7.5 Chongqing Haifu Medical Recent Developments
- 4.8 HealthTronics
- 4.8.1 HealthTronics Company Information
- 4.8.2 HealthTronics Business Overview
- 4.8.3 HealthTronics Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 HealthTronics Tumor Ablation Product Portfolio
- 4.8.5 HealthTronics Recent Developments
- 4.9 J &J
- 4.9.1 J &J Company Information
- 4.9.2 J &J Business Overview
- 4.9.3 J &J Tumor Ablation Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 J &J Tumor Ablation Product Portfolio
- 4.9.5 J &J Recent Developments
5 Global Tumor Ablation Market Scenario by Region
- 5.1 Global Tumor Ablation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tumor Ablation Sales by Region: 2021-2032
- 5.2.1 Global Tumor Ablation Sales by Region: 2021-2026
- 5.2.2 Global Tumor Ablation Sales by Region: 2027-2032
- 5.3 Global Tumor Ablation Revenue by Region: 2021-2032
- 5.3.1 Global Tumor Ablation Revenue by Region: 2021-2026
- 5.3.2 Global Tumor Ablation Revenue by Region: 2027-2032
- 5.4 North America Tumor Ablation Market Facts & Figures by Country
- 5.4.1 North America Tumor Ablation Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tumor Ablation Sales by Country (2021-2032)
- 5.4.3 North America Tumor Ablation Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Tumor Ablation Market Facts & Figures by Country
- 5.5.1 Europe Tumor Ablation Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tumor Ablation Sales by Country (2021-2032)
- 5.5.3 Europe Tumor Ablation Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Tumor Ablation Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tumor Ablation Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tumor Ablation Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tumor Ablation Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tumor Ablation Market Facts & Figures by Country
- 5.7.1 South America Tumor Ablation Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tumor Ablation Sales by Country (2021-2032)
- 5.7.3 South America Tumor Ablation Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Tumor Ablation Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tumor Ablation Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tumor Ablation Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tumor Ablation Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Tumor Ablation Sales by Type (2021-2032)
- 6.1.1 Global Tumor Ablation Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Tumor Ablation Sales Market Share by Type (2021-2032)
- 6.2 Global Tumor Ablation Revenue by Type (2021-2032)
- 6.2.1 Global Tumor Ablation Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tumor Ablation Revenue Market Share by Type (2021-2032)
- 6.3 Global Tumor Ablation Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tumor Ablation Sales by Application (2021-2032)
- 7.1.1 Global Tumor Ablation Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Tumor Ablation Sales Market Share by Application (2021-2032)
- 7.2 Global Tumor Ablation Revenue by Application (2021-2032)
- 7.2.1 Global Tumor Ablation Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tumor Ablation Revenue Market Share by Application (2021-2032)
- 7.3 Global Tumor Ablation Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tumor Ablation Value Chain Analysis
- 8.1.1 Tumor Ablation Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tumor Ablation Production Mode & Process
- 8.2 Tumor Ablation Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tumor Ablation Distributors
- 8.2.3 Tumor Ablation Customers
9 Global Tumor Ablation Analyzing Market Dynamics
- 9.1 Tumor Ablation Industry Trends
- 9.2 Tumor Ablation Industry Drivers
- 9.3 Tumor Ablation Industry Opportunities and Challenges
- 9.4 Tumor Ablation Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst